Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway.
about
Matrine derivate MASM uncovers a novel function for ribosomal protein S5 in osteoclastogenesis and postmenopausal osteoporosis.Cbfβ governs osteoblast-adipocyte lineage commitment through enhancing β-catenin signaling and suppressing adipogenesis gene expression.Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption.18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK–TRAF6 Interactions and NF-κB and MAPK Signaling Pathways.
P2860
Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gα13 negatively controls osteo ...... K3β-NFATc1 signalling pathway.
@en
Gα13 negatively controls osteo ...... K3β-NFATc1 signalling pathway.
@nl
type
label
Gα13 negatively controls osteo ...... K3β-NFATc1 signalling pathway.
@en
Gα13 negatively controls osteo ...... K3β-NFATc1 signalling pathway.
@nl
prefLabel
Gα13 negatively controls osteo ...... K3β-NFATc1 signalling pathway.
@en
Gα13 negatively controls osteo ...... K3β-NFATc1 signalling pathway.
@nl
P2093
P2860
P356
P1476
Gα13 negatively controls osteo ...... SK3β-NFATc1 signalling pathway
@en
P2093
P2860
P2888
P356
10.1038/NCOMMS13700
P407
P50
P577
2017-01-19T00:00:00Z